TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 36.00
0.00 (0.00%)
Oct 30, 2026, 12:07 PM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 772.51 million as of October 30, 2026. It is the 34,315th most valuable company in the world and the 2,070th biggest in Taiwan. Its market cap has decreased by 25.14% in one year.
Market Cap
772.51M
Enterprise Value
459.82M
Revenue
251.39M
Global Rank
Country Rank
#2,070 Taiwan
PE Ratio
18.96
ChartMarket Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 772.51M, a decrease of -63.82%. That is a compound annual growth rate of -19.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 772.51M | -17.76% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LabTurbo Biotech | 1.11B |
| Bio Preventive Medicine | 1.09B |
| BiOptic | 1.01B |
| Level Biotechnology | 994.68M |
| Holy Stone Healthcare | 979.49M |
| GeneReach Biotechnology | 946.69M |
| Enimmune | 918.00M |
| MegaPro Biomedical | 906.09M |